Clinical Trial

LDRT and Chemoimmunotherapy in NPC With Liver Metastasis

Study acronym: Light
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the efficacy and toxicity of adding low-dose radiotherapy to chemoimmunotherapy as a first-line treatment for nasopharyngeal carcinoma patients with liver metastasis.
Protocol Amendment History 3 amendments
This ClinicalTrials.gov record has been amended 3 times since 2025-01-16; most recent amendment 2026-07-05.
Trial Details
NCT Number NCT06788002
Lead Sponsor Hunan Cancer Hospital
Conditions Nasopharyngeal Cancinoma (NPC)
Enrollment 26 participants
Start Date 2025-01-14
Primary Completion 2026-06-30 (estimated)
Study Completion 2027-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-07-07